Page last updated: 2024-12-06

1-adamantanecarboxamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

## 1-Adamantanecarboxamide: A Promising Molecule for Research

1-Adamantanecarboxamide, also known as **amantadine**, is a drug that has been used for decades to treat Parkinson's disease and influenza A. However, its research significance extends beyond these therapeutic applications, highlighting its potential in various fields.

**Here's a breakdown of its importance:**

**1. Therapeutic Potential:**

* **Parkinson's Disease:** Amantadine was one of the first medications approved for Parkinson's disease. It works by increasing dopamine levels in the brain, alleviating symptoms like tremors and rigidity.
* **Influenza A:** Amantadine has antiviral activity against influenza A virus, particularly effective in treating the initial stages of infection. However, its effectiveness has declined with the emergence of resistant strains.

**2. Research Applications:**

* **Neuroprotection:** Studies suggest that amantadine may protect neurons from damage, potentially benefiting conditions like stroke and Alzheimer's disease.
* **Anti-inflammatory:** It has shown potential in reducing inflammation, particularly in conditions like rheumatoid arthritis and multiple sclerosis.
* **Cognitive Enhancement:** Some research suggests that amantadine might improve cognitive function, potentially helping with memory and attention.
* **Cancer Therapy:** Amantadine is being investigated for its potential in cancer treatment, particularly in inhibiting tumor growth and angiogenesis (formation of new blood vessels that feed tumors).

**3. Unique Properties:**

* **Adamantane Scaffold:** Amantadine's structure incorporates the rigid adamantane cage, providing unique properties like high stability and potential for drug delivery.
* **Versatile Chemistry:** The carboxamide group allows for modification and conjugation with other molecules, expanding its potential applications.

**4. Ongoing Research:**

* **New Formulations and Delivery Systems:** Researchers are developing new formulations and delivery methods to enhance amantadine's effectiveness and reduce side effects.
* **Mechanism of Action:** Further research is needed to understand the exact mechanisms by which amantadine exerts its therapeutic effects, which could lead to more targeted drug development.
* **New Therapeutic Applications:** Ongoing research is exploring amantadine's potential in treating a wide range of conditions, including drug addiction, neurodegenerative disorders, and autoimmune diseases.

**In conclusion, 1-adamantanecarboxamide, despite being known for its clinical applications, holds significant promise in research. Its unique properties, potential for various therapeutic applications, and ongoing research make it a molecule worth watching in the future of drug development.**

Cross-References

ID SourceID
PubMed CID21686
CHEMBL ID2041315
SCHEMBL ID176523
MeSH IDM0269110

Synonyms (41)

Synonym
HMS1786F09
brn 2047887
tricyclo(3.3.1.1(sup 3,7))decane-1-carboxamide
tricyclo[3.3.1.1~3,7~]decane-1-carboxamide
STL290663
1-adamantanecarboxamide
tricyclo(3.3.1.13,7)decane-1-carboxamide
EU-0066815
OPREA1_331138
1-adamantanecarboxamide, 97%
5511-18-2
adamantane-1-carboxamide
perazine-d8 dihydrochloride salt
9-minocycline-d6 disulfate salt
AKOS001023937
adamantanecarboxamide
A830495
adamantane-1-carboxylic acid amide
CHEMBL2041315
GEO-02752
FT-0621897
AKOS017344467
SCHEMBL176523
admantane-1-carboxamide
CKBZJTAMRPPVSR-UHFFFAOYSA-N
2,4-dinitrophenyltaurinesodiumsalt
W-200426
DTXSID30203628
sr-01000389674
SR-01000389674-1
mfcd00077200
AS-58216
1246815-57-5
Z56757306
1-adamantyl-carboxamide
BB 0266540
1316291-16-3
CS-0149960
1-adamantane carboxamide
SY031536
EN300-1718711
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID668903Inhibition of Influenza A Virus M2 proton channel expressed in Xenopus laevis oocytes at 100 uM after 2 mins by two-electrode patch clamp assay2011ACS medicinal chemistry letters, Apr-14, Volume: 2, Issue:4
Exploring the Requirements for the Hydrophobic Scaffold and Polar Amine in inhibitors of M2 from Influenza A Virus.
AID668905Inhibition of Influenza A Virus M2 proton channel V27A mutant expressed in Xenopus laevis oocytes at 100 uM after 2 mins by two-electrode patch clamp assay2011ACS medicinal chemistry letters, Apr-14, Volume: 2, Issue:4
Exploring the Requirements for the Hydrophobic Scaffold and Polar Amine in inhibitors of M2 from Influenza A Virus.
AID668906Inhibition of Influenza A Virus M2 proton channel S31N mutant expressed in Xenopus laevis oocytes at 100 uM after 2 mins by two-electrode patch clamp assay2011ACS medicinal chemistry letters, Apr-14, Volume: 2, Issue:4
Exploring the Requirements for the Hydrophobic Scaffold and Polar Amine in inhibitors of M2 from Influenza A Virus.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.87 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]